Data protection Impressum

Personalized Medicine

Spirecut, a Swiss medtech pioneer in ultrasound-guided hand surgery, has inaugurated Switzerland’s first Center of Excellence at the Clinique de la Main in Geneva. The center aims to train surgeons in the SonoSurgery technique while supporting research into new applications for Spirecut’s Sono-Instruments®.

Spirecut opens Switzerland’s first Center of Excellence for ultrasound-guided hand surgery

17 December 2024

Rhovica Neuroimaging AG, an innovative bernse medtech start-up, has announced a strategic partnership with M2care, a European venture studio specializing in health technologies. This collaboration aims to accelerate the development and commercialization of Rhovica’s cutting-edge solutions in neurocritical care.

Rhovica Neuroimaging partners with M2care to advance neurosurgery

9 December 2024

Biopôle, the renowned life sciences campus in Epalinges-Lausanne, celebrates 20 years of groundbreaking achievements with the inauguration of the Leucine Building.

Biopôle celebrates 20 years of innovation with the inauguration of the Leucine building

9 December 2024

Biolux Technology, a Geneva-based pioneer in light-accelerated orthodontics, has raised CHF 4 million in seed funding to revolutionize orthodontic care with cutting-edge digital solutions.

Geneva’s Biolux Technology secures CHF 4 million to advance orthodontic innovation

20 November 2024

Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases. The study, conducted with leading academic and industrial partners, demonstrates the model's potential for personalized and ethical testing.

AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research

4 November 2024

ONWARD Medical has raised EUR 50 million through an upsized private placement, establishing a strategic partnership with Ottobock. The funds will drive ONWARD’s research and commercialization of spinal cord therapies, with plans for collaboration with Ottobock on future innovations.

ONWARD Medical raises EUR 50 million and welcomes a new strategic partner

28 October 2024

Lymphatica Medtech, a Lausanne-based clinical-stage company specializing in innovative treatments for lymphedema, has raised EUR 17.9 million in a Series B funding round.

Lymphatica Medtech secures EUR 17.9 million to advance lymphedema treatment

15 October 2024

The newly inaugurated Genolier Innovation Hub, a 270,000-square-foot facility, offers companies, researchers and healthcare professionals an interdisciplinary platform to foster medical breakthroughs, backed by a CHF 100 million investment.

The Genolier Innovation Hub, a cutting-edge medical innovation center, was inaugurated

30 September 2024

Novostia has raised CHF 5.6 million in a new financing round and appointed Soad El Ghazouani as CEO to accelerate the development of its TRIFLO heart valve technology.

Novostia secures CHF 5.6 million to accelerate the development of its heart valve

24 September 2024

ONWARD Medical has secured a USD 1.1 million grant from the Christopher & Dana Reeve Foundation to further develop its ARC-BCI system, which aims to restore thought-controlled movement to people with spinal cord injuries.

ONWARD Medical awarded USD 1.1 million by the Christopher & Dana Reeve Foundation

17 September 2024

1 2 3 4 5 6 7 … 17